Endocrinology status update: Difference between revisions
Jump to navigation
Jump to search
Line 670: | Line 670: | ||
|- | |- | ||
| rowspan="88" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |CVS | | rowspan="88" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |CVS | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Abdominal aortic aneurysm]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Abdominal aortic aneurysm|Diabetes Landing Page]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | | style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | ||
Line 678: | Line 678: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Acute coronary syndromes]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Acute coronary syndromes|Diabetes Type I]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon | | style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon | ||
Line 686: | Line 686: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Acute aortic syndrome]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Acute aortic syndrome|Diabetes Type II]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar | | style="padding: 5px 5px; background: #F5F5F5;" |Sahar | ||
Line 694: | Line 694: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Diabetes insipidus | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar | | style="padding: 5px 5px; background: #F5F5F5;" |Sahar | ||
Line 702: | Line 702: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Pituitary disorders landing page | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cafer Zorkon | | style="padding: 5px 5px; background: #F5F5F5;" |Cafer Zorkon | ||
Line 710: | Line 710: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hypopituitarism | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mandana | | style="padding: 5px 5px; background: #F5F5F5;" |Mandana | ||
Line 718: | Line 718: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sheehan Syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Javaria Anwer | | style="padding: 5px 5px; background: #F5F5F5;" |Javaria Anwer | ||
Line 726: | Line 726: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Atrial fibrillation]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Atrial fibrillation|Sheehan Syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan | | style="padding: 5px 5px; background: #F5F5F5;" |Hasan | ||
Line 750: | Line 750: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sheehan Syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Shadi Ebr | | style="padding: 5px 5px; background: #F5F5F5;" |Shadi Ebr | ||
Line 758: | Line 758: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Blalock-Taussig shunt]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Blalock-Taussig shunt|Hypogonadism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Usman Ali Akbar | | style="padding: 5px 5px; background: #F5F5F5;" |Usman Ali Akbar | ||
Line 766: | Line 766: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Brugada syndrome]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Brugada syndrome|GH deficiency]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
Line 774: | Line 774: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Bundle branch block| | | style="padding: 5px 5px; background: #F5F5F5;" |[[Bundle branch block|Prolactinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | | style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | ||
Line 782: | Line 782: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac amyloidosis]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac amyloidosis|Acromegaly]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon | | style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon | ||
Line 790: | Line 790: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac tamponade]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac tamponade|Pituitary apoplexy]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | | style="padding: 5px 5px; background: #F5F5F5;" |Ramyar | ||
Line 798: | Line 798: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac fibrosis]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac fibrosis|Thyroid disorders landing page]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Niloofar | | style="padding: 5px 5px; background: #F5F5F5;" |Niloofar | ||
Line 806: | Line 806: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiogenic shock]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiogenic shock|Hyperthyroidism landing page]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ali | | style="padding: 5px 5px; background: #F5F5F5;" |Ali | ||
Line 814: | Line 814: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac transplantation]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac transplantation|Graves Disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ifrah Fatima | | style="padding: 5px 5px; background: #F5F5F5;" |Ifrah Fatima | ||
Line 822: | Line 822: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Chagas disease]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Chagas disease|Goiter]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Huda | | style="padding: 5px 5px; background: #F5F5F5;" |Huda | ||
Line 830: | Line 830: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Congenital heart block]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Congenital heart block|Toxic Multinodular goiter]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
Line 838: | Line 838: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Constrictive pericarditis]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Constrictive pericarditis|Toxic adenoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Huda | | style="padding: 5px 5px; background: #F5F5F5;" |Huda | ||
Line 846: | Line 846: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cyanotic heart disease]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cyanotic heart disease|Struma ovarii]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime | | style="padding: 5px 5px; background: #F5F5F5;" |Fahime | ||
Line 854: | Line 854: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Dressler's syndrome]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Dressler's syndrome|Hypothyroidism landing page]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman | | style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman | ||
Line 862: | Line 862: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Ebstein's anomaly]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Ebstein's anomaly|Primary hypothyroidism (hypothyroidism)]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | | style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | ||
Line 870: | Line 870: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |[[Eisenmenger's syndrome]] | | style="padding: 5px 5px; background: #F5F5F5;" |[[Eisenmenger's syndrome|Hashimoto thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman | | style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman | ||
Line 878: | Line 878: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya |
Revision as of 02:47, 22 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
System leader: Sogand Goudarzi, M.D.
Progress | |
---|---|
Completed | |
In progress | |
Remaining |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Endocrinology | Pheochromocytoma | Assigned | Ifrah | Sogand | In Progress | ||
Metabolic syndrome X | Assigned | Mina | Sogand | In Progress | |||
Gestentional Diabetes | |||||||
Disbetes Insipidus | Assigned | Anahita | Krishna | In Progress | |||
Hypopitutarism | |||||||
Sheenhan's Syndrome | |||||||
Hypogonadism | |||||||
GH deficiency | |||||||
Primary hyperaldostronism | |||||||
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Endocrinology | Metabolic syndrome X | Assigned | Fatemeh Dehghani Fiouzabadi | Sogand | In progress | Sogand | |
DM Type I | Assigned | Sogand | In progress | ||||
Disbetes Insipidus | Assigned | Anahita | Krishna | In progress | |||
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Obstetrics | Diabetes Landing Page | ||||||
Diabetes Type I | |||||||
Diabetes Type II | |||||||
GDM | |||||||
Diabetes insipidus | |||||||
Pituitary disorders landing page | |||||||
Hypopituitarism | |||||||
Sheehan Syndrome | |||||||
Hypogonadism | |||||||
GH deficiency | |||||||
Prolactinoma | |||||||
Acromegaly | |||||||
Pituitary apoplexy | |||||||
Thyroid disorders landing page | |||||||
Hyperthyroidism landing page | |||||||
Graves Disease | |||||||
Toxic Multinodular goiter | |||||||
Goiter | |||||||
Toxic adenoma | |||||||
Struma ovarii | |||||||
Hypothyroidism landing page | |||||||
Primary hypothyroidism (hypothyroidism) | |||||||
Hashimoto thyroiditis | |||||||
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
CVS | Diabetes Landing Page | Assigned | Ramyar | Complete | In progress | ||
Diabetes Type I | Assigned | Sabawoon | Complete | In progress | |||
Diabetes Type II | Assigned | Sahar | Complete | In progress | |||
Diabetes insipidus | Assigned | Sahar | Complete | In progress | |||
Pituitary disorders landing page | Assigned | Cafer Zorkon | Complete | In progress | |||
Hypopituitarism | Assigned | Mandana | Complete | In progress | |||
Sheehan Syndrome | Assigned | Javaria Anwer | Farima | Complete | In progress | ||
Sheehan Syndrome | Assigned | Hasan | Complete | In progress | |||
Atrial septal defect | Assigned | Ifeoma | Complete | In progress | |||
Beri Beri | Assigned | Abdelrahman | Complete | In progress | |||
Sheehan Syndrome | Assigned | Shadi Ebr | Sahar | Complete | In progress | ||
Hypogonadism | Assigned | Usman Ali Akbar | Sara | Complete | In progress | ||
GH deficiency | Assigned | Sogand | Complete | In progress | |||
Prolactinoma | Assigned | Maneesha | Complete | In progress | |||
Acromegaly | Assigned | Sabawoon | Complete | In progress | |||
Pituitary apoplexy | Assigned | Ramyar | Complete | In progress | |||
Thyroid disorders landing page | Assigned | Niloofar | Complete | In progress | |||
Hyperthyroidism landing page | Assigned | Ali | Complete | In progress | |||
Graves Disease | Assigned | Ifrah Fatima | Sogand | Complete | In progress | ||
Goiter | Assigned | Huda | Complete | In progress | |||
Toxic Multinodular goiter | Assigned | Sogand | Complete | In progress | |||
Toxic adenoma | Assigned | Huda | Complete | In progress | |||
Struma ovarii | Assigned | Fahime | Complete | In progress | |||
Hypothyroidism landing page | Assigned | Abdelrahman | Complete | In progress | |||
Primary hypothyroidism (hypothyroidism) | Assigned | Maneesha | Complete | In progress | |||
Hashimoto thyroiditis | Assigned | Abdelrahman | Complete | In progress | |||
Assigned | Aditya | Complete | In progress | ||||
Endocarditis | Assigned | Fahime | Complete | In progress | |||
Dilated cardiomyopathy | Assigned | Abdelrahman | Complete | In progress | |||
First degree AV block | Assigned | Ahmed | Complete | In progress | |||
Heart Failure | Assigned | Hasan | Complete | In progress | |||
Heart in Kawasaki disease | Assigned | Sabawoon | Complete | In progress | |||
HIV induced pericarditis | Assigned | Ramyar | Complete | In progress | |||
Holiday heart syndrome | Assigned | Apeksha Gupta | Aditya | Complete | In progress | ||
Hypertrophic obstructive cardiomyopathy | Assigned | Soroush | Complete | In progress | |||
Kawasaki disease | Assigned | Fahime | Complete | In progress | |||
Jervel Lange Nielson Syndrome | Assigned | Krishna | Complete | In progress | |||
Libman-Sacks endocarditis | Assigned | Sara | Complete | In progress | |||
Long QT syndrome (LQTS) | Assigned | Krishna | Complete | In progress | |||
Loeffler endocarditis | Assigned | Soroush | Complete | In progress | |||
Mitral stenosis | Assigned | Aditya | Complete | In progress | |||
Myocardial abscess | Assigned | Ali | Complete | In progress | |||
Myocarditis | Assigned | Homa | Complete | In progress | |||
Myxoma | Assigned | Sogand | Complete | In progress | |||
Myxomatous degeneration | Assigned | Ali | Complete | In progress | |||
Nonbacterial thrombotic endocarditis | Assigned | Homa | Complete | In progress | |||
Obesity cardiomyopathy | Assigned | Soroush | Complete | In progress | |||
Paget-Schroetter disease | Assigned | Anahita Deylamshahi | Krishna | Complete | In progress | ||
Parasystole | Assigned | Mohammed Salih | Complete | In progress | |||
Paroxysmal AV block | Assigned | Akash Daswaney | Homa | Complete | In progress | ||
Patent ductus arteriosus | Assigned | Ramyar | Complete | In progress | |||
Patent foramen ovale | Assigned | Ifoma | Complete | In progress | |||
Penetrating atherosclerotic aortic ulcer | Assigned | Sahar | Complete | In progress | |||
Pentalogy of Fallot | Assigned | Abdulkareem Lukan | Sahar | Complete | In progress | ||
Pericardial effusion | Assigned | Abdelrahman | Complete | In progress | |||
Post-cardiac injury syndrome | Assigned | Ibtisam Ashraf | Sahar | Complete | In progress | ||
Post myocardial infarction pericarditis | Assigned | Mandana | Complete | In progress | |||
Postpericardiotomy syndrome | Assigned | Niloofar | Complete | In progress | |||
Pericarditis | Assigned | Homa | Complete | In progress | |||
Pre-excitation syndrome | Assigned | Shivam | Sara | Complete | In progress | ||
Premature atrial contraction | Assigned | Amandeep | Complete | In progress | |||
Prinzmetal's angina | Assigned | Amandeep | Complete | In progress | |||
Restrictive Cardiomyopathy | Assigned | Maneesha | Complete | In progress | |||
Rheumatic heart disease | Assigned | Huda | Complete | In progress | |||
2nd degree heart block | Assigned | Ahmed | Complete | In progress | |||
Sick sinus syndrome | Assigned | Sahar | Complete | In progress | |||
Supraventricular tachycardia | Assigned | Abdelrahman | Complete | In progress | |||
Tetralogy of Fallot | Assigned | Fahime | Complete | In progress | |||
Third degree AV block | Assigned | Qasim Khurshid | Maneesha | Complete | In progress | ||
Transesophageal echocardiography | Assigned | Shakiba Hassanzadeh | Ahmed | Complete | In progress | ||
Transposition of great arteries | Assigned | Aditya | Complete | In progress | |||
Tricuspid atresia | Assigned | Sara Zand | Fahime | Complete | In progress | ||
Tricuspid regurgitation | Assigned | Krishna | Complete | In progress | |||
Timothys syndrome | Assigned | Krishna | Complete | In progress | |||
Tuberculous pericarditis | Assigned | Fahime | Complete | In progress | |||
Ventricular septal defect | Assigned | Huda | Complete | In progress | |||
Ventricular fibrillation | Assigned | Sahar | Complete | In progress | |||
Long QT syndrome | Assigned | Complete | In progress | ||||
Angina pectoris | Assigned | Complete | In progress | ||||
Mitral regurgitation | Assigned | Complete | In progress | ||||
Pulmonary valve regurgitation | Assigned | Complete | In progress | ||||
Preoperative cardiac risk assessment | Assigned | Complete | In progress | ||||
Percutaneous coronary intervention | Assigned | Complete | In progress |